IP-6 RESEARCH

In the laboratory, IP 6 ± Inositol have been shown to have consistent and reproducible anti-cancer action against a wide range of cancer models (eg. breast, colon, leukemia, liver, lung, lymphoma, prostate, sarcoma etc) making it a broad-spectrum anti-cancer agent. This anti-cancer action is both preventive and therapeutic, and the combination of IP 6 + Inositol in correct proportion (US Patent # 5,082,833) yields the best results. Emerging clinical data confirm the laboratory findings... Shown are two mice #11 and #12 harboring human liver cancer. The mouse on the upper panel shows complete regression of the tumor 1 week after IP 6 treatment (40 mg/kg/day; right frame), whereas within the same period, the tumor in its sibling on the lower panel has grown 2-3 fold in size (right frame)... Learn how the B vitamin inositol and its derivative IP6 prevent cancer, Alzheimer's disease, osteoporosis; protect against radiation; lower cholesterol, boost immunity...

Also known as: IP-6 Research, Inc., IP6

Primary location: Baltimore United States